Communication Bridge 3 Study

Description

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Conditions

Primary Progressive Aphasia

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia

Communication Bridge 3 Study

Condition
Primary Progressive Aphasia
Intervention / Treatment

-

Contacts and Locations

Chicago

University of Chicago - American School Building, Chicago, Illinois, United States, 60637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * A dementia diagnosis other than Primary Progressive Aphasia
  • * Participation is co-enrolled in an outside speech language therapy program during the study course.
  • * Communication partners will be excluded if they have a pre-existing communication impairment that would affect study participation (e.g., aphasia, dementia)

Ages Eligible for Study

18 Years to 100 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Chicago,

Emily Roglaski, PhD, PRINCIPAL_INVESTIGATOR, Professor of Neurology

Study Record Dates

2028-07-15